Scarica l'app Stockscreener
23.07
0.39%
-0.065
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AMPH Giù?
Forum
Previsione
Precedente Chiudi:
$23.14
Aprire:
$23.13
Volume 24 ore:
262.23K
Relative Volume:
0.53
Capitalizzazione di mercato:
$1.07B
Reddito:
$722.68M
Utile/perdita netta:
$134.71M
Rapporto P/E:
8.6423
EPS:
2.67
Flusso di cassa netto:
$109.94M
1 W Prestazione:
-7.69%
1M Prestazione:
-14.63%
6M Prestazione:
+0.26%
1 anno Prestazione:
-54.65%
Intervallo 1D:
$22.94
$23.61
Intervallo di 1 settimana:
$22.94
$25.02
Portata 52W:
$20.39
$53.95
Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile
Nome
Amphastar Pharmaceuticals Inc
Settore
Telefono
909-980-9484
Indirizzo
11570 SIXTH STREET, RANCHO CUCAMONGA, CA
Confronta AMPH con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AMPH
Amphastar Pharmaceuticals Inc
|
23.06 | 1.11B | 722.68M | 134.71M | 109.94M | 2.67 |
|
ZTS
Zoetis Inc
|
143.65 | 63.58B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.92 | 43.58B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.205 | 40.83B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.77 | 23.07B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
430.10 | 19.61B | 3.08B | 1.24B | 1.07B | 25.61 |
Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-12 | Aggiornamento | Needham | Hold → Buy |
| 2025-05-12 | Downgrade | JP Morgan | Overweight → Neutral |
| 2025-02-04 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2024-11-22 | Iniziato | Wells Fargo | Equal Weight |
| 2024-03-05 | Iniziato | JP Morgan | Overweight |
| 2023-11-17 | Iniziato | BofA Securities | Neutral |
| 2023-07-25 | Ripresa | Jefferies | Buy |
| 2022-10-21 | Ripresa | Jefferies | Buy |
| 2022-07-29 | Iniziato | CapitalOne | Overweight |
| 2022-01-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-01-08 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2020-10-05 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2020-05-01 | Iniziato | Northland Capital | Outperform |
| 2019-03-13 | Downgrade | Needham | Buy → Hold |
| 2019-03-13 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2018-08-10 | Reiterato | Needham | Buy |
| 2018-03-13 | Reiterato | Needham | Buy |
| 2017-12-01 | Reiterato | Needham | Buy |
| 2017-11-09 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2017-09-27 | Reiterato | Needham | Buy |
| 2017-03-14 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2016-08-09 | Reiterato | Needham | Buy |
| 2016-05-10 | Reiterato | Needham | Buy |
| 2016-02-19 | Iniziato | Wells Fargo | Outperform |
| 2015-06-19 | Reiterato | Needham | Buy |
| 2015-06-03 | Iniziato | Raymond James | Strong Buy |
| 2014-07-21 | Iniziato | Needham | Buy |
Mostra tutto
Amphastar Pharmaceuticals Inc Borsa (AMPH) Ultime notizie
Will Amphastar Pharmaceuticals Inc. (29A) stock beat international competition2025 Historical Comparison & Momentum Based Trading Signals - newser.com
Will Amphastar Pharmaceuticals Inc. stock deliver shareholder valueOptions Play & Scalable Portfolio Growth Ideas - newser.com
Why Amphastar Pharmaceuticals Inc. stock is a value investor pickJuly 2025 Trends & Weekly Return Optimization Alerts - newser.com
Should you wait for a breakout in Amphastar Pharmaceuticals Inc.Market Activity Report & Low Risk Profit Maximizing Plans - newser.com
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Given Average Recommendation of "Hold" by Brokerages - MarketBeat
Boston Trust Walden Corp Lowers Holdings in Amphastar Pharmaceuticals, Inc. $AMPH - MarketBeat
What’s next for Amphastar Pharmaceuticals Inc. stock priceEarnings Recap Report & Low Risk High Win Rate Stock Picks - newser.com
Will Amphastar Pharmaceuticals Inc. (29A) stock gain from lower interest ratesJuly 2025 Decliners & Long-Term Growth Plans - newser.com
Using economic indicators to assess Amphastar Pharmaceuticals Inc. potentialAnalyst Downgrade & Precise Swing Trade Entry Alerts - newser.com
Does Amphastar Pharmaceuticals Inc. stock trade at a discount to peersQuarterly Market Summary & Free Risk Controlled Daily Trade Plans - newser.com
Can Amphastar Pharmaceuticals (AMPH) Navigate Heightened Trade Tensions to Protect Its Supply Chain Advantage? - Sahm
A Fresh Valuation Look at Amphastar Pharmaceuticals (AMPH) After US-China Trade Tensions Shake Healthcare Stocks - Sahm
What drives Amphastar Pharmaceuticals Inc 29A stock priceTrading Volume Trends & Free Short-Term Trading Strategies - earlytimes.in
Align Technology, Envista, Centene, Amphastar Pharmaceuticals, and Oscar Health Shares Plummet, What You Need To Know - Yahoo Finance
BofA Cuts Price Target on Amphastar Pharmaceuticals to $31 From $32 - MarketScreener
Teva, Viatris On Investor Watch As White House Spares Generic Drugs From Tariffs - Benzinga
Can Amphastar Pharmaceuticals Inc. stock attract ESG capital inflowsMarket Volume Report & Daily Entry Point Trade Alerts - newser.com
How to monitor Amphastar Pharmaceuticals Inc. with trend dashboardsQuarterly Risk Review & Safe Capital Growth Trade Ideas - newser.com
Will Amphastar Pharmaceuticals Inc. stock recover after recent dropMarket Volume Summary & Expert Curated Trade Setups - newser.com
Amphastar Pharmaceuticals' (AMPH) Hold (C-) Rating Reaffirmed at Weiss Ratings - MarketBeat
Will Amphastar Pharmaceuticals Inc. (29A) stock return to pre crash levels2025 Volume Leaders & Growth Focused Entry Reports - newser.com
What analysts say about Cochlear Limited OC5 stockIPO Market Watch & Zero-Cost Stock Research by Professionals - earlytimes.in
Momentum divergence signals in Amphastar Pharmaceuticals Inc. chartAnalyst Downgrade & Precise Swing Trade Entry Alerts - newser.com
Amphastar Pharmaceuticals to Present at the 2025 Bank of America Health Care Conference - 富途牛牛
Is Amphastar Pharmaceuticals Inc. (29A) stock cheap vs fundamentalsEarnings Trend Report & Expert Approved Momentum Ideas - newser.com
Amphastar Pharmaceuticals (NASDAQ:AMPH) Director Sells 500 Shares - MarketBeat
Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Exploring a 21.35% Potential Upside - DirectorsTalk Interviews
What analysts say about Amphastar Pharmaceuticals Inc stockPrice Momentum Alerts & Small Entry Cost Portfolio - earlytimes.in
Amphastar Pharmaceuticals Inc Azioni (AMPH) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.83%
0.45%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):